NO20081589L - 2-aminoalkoholer for behandling av neurodegenerative sykdommer - Google Patents

2-aminoalkoholer for behandling av neurodegenerative sykdommer

Info

Publication number
NO20081589L
NO20081589L NO20081589A NO20081589A NO20081589L NO 20081589 L NO20081589 L NO 20081589L NO 20081589 A NO20081589 A NO 20081589A NO 20081589 A NO20081589 A NO 20081589A NO 20081589 L NO20081589 L NO 20081589L
Authority
NO
Norway
Prior art keywords
alkyl
conh2
treatment
ring
neurodegenerative diseases
Prior art date
Application number
NO20081589A
Other languages
English (en)
Norwegian (no)
Inventor
Robin Mark Bannister
Michael Harvey Lyne
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of NO20081589L publication Critical patent/NO20081589L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20081589A 2005-09-21 2008-04-01 2-aminoalkoholer for behandling av neurodegenerative sykdommer NO20081589L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0519274.5A GB0519274D0 (en) 2005-09-21 2005-09-21 The treatment of neurodegenerative diseases
PCT/GB2006/003529 WO2007034200A1 (en) 2005-09-21 2006-09-21 2-aminoalcohols for the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
NO20081589L true NO20081589L (no) 2008-04-16

Family

ID=35335212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081589A NO20081589L (no) 2005-09-21 2008-04-01 2-aminoalkoholer for behandling av neurodegenerative sykdommer

Country Status (12)

Country Link
US (2) US8188152B2 (de)
EP (1) EP1928443A1 (de)
JP (1) JP5032482B2 (de)
KR (1) KR20080046202A (de)
CN (1) CN101291661A (de)
AU (1) AU2006293671B2 (de)
BR (1) BRPI0616392A2 (de)
CA (1) CA2623092A1 (de)
GB (1) GB0519274D0 (de)
IL (1) IL190182A0 (de)
NO (1) NO20081589L (de)
WO (1) WO2007034200A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0604824D0 (en) * 2006-03-09 2006-04-19 Arakis Ltd The treatment of inflammatory disorders
GB0624757D0 (en) * 2006-12-12 2007-01-17 Sosei R & D Ltd Novel compounds
GB2484977A (en) * 2010-10-29 2012-05-02 Biocopea Ltd Treatment of a Th-1 mediated disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264459A (en) * 1992-07-13 1993-11-23 Arch Development Corporation Use of β-adrenergic agonists to treat patients with demyelinating or autoimmune diseases
NZ509198A (en) * 1998-06-26 2002-11-26 Elaine A Treatment for multiple sclerosis using a histamine H2 agonist in combination with a phosphodiesterase inhibitor
US6337328B1 (en) * 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6342496B1 (en) 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
IL138686A0 (en) * 1999-10-01 2001-10-31 Pfizer Prod Inc α- SULFONYLAMINO HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVOUS SYSTEM DISORDERS
IL153594A0 (en) * 2000-07-13 2003-07-06 Sankyo Co Amino alcohol derivatives and pharmaceutical compositions containing the same
AU2002333510A1 (en) * 2001-08-29 2003-03-18 Eucro European Contract Research Gmbh And Co. Kg Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases
US20040002546A1 (en) * 2001-09-15 2004-01-01 Eric Altschuler Methods for treating crohn's and other TNF associated diseases
GB0325957D0 (en) * 2003-11-06 2003-12-10 Arakis Ltd The treatment of pain
EP1725226A2 (de) * 2004-03-17 2006-11-29 Sosei R&D Ltd. Behandlung von entzündlichen erkrankungen und schmerz mit beta-aminalkoholen
KR101406456B1 (ko) * 2005-04-06 2014-06-20 아다마스 파마슈티칼스, 인코포레이티드 Ｃｎｓ 장애의 치료를 위한 방법 및 조성물

Also Published As

Publication number Publication date
JP5032482B2 (ja) 2012-09-26
EP1928443A1 (de) 2008-06-11
US8188152B2 (en) 2012-05-29
JP2009508926A (ja) 2009-03-05
AU2006293671B2 (en) 2010-07-01
CN101291661A (zh) 2008-10-22
US20120269767A1 (en) 2012-10-25
IL190182A0 (en) 2008-11-03
WO2007034200A1 (en) 2007-03-29
KR20080046202A (ko) 2008-05-26
US20090192229A1 (en) 2009-07-30
BRPI0616392A2 (pt) 2011-06-21
GB0519274D0 (en) 2005-11-02
CA2623092A1 (en) 2007-03-29
AU2006293671A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
WO2006027579A3 (en) The treatment of inflammatory disorders and pain
ME01089B (me) Derivat benzimidazola i njegova upotreba kao antagonista receptora aii
ATE398125T1 (de) Chinazolin-derivate als tgf-beta-inhibitoren
AR046046A1 (es) Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
AR052156A1 (es) Fenil-metanonas bi- y triciclicas sustituidas para el tratamiento de trastornos neurologicos y neuropsiquiatricos
AR064459A1 (es) Derivados de sulfonamida
ATE464309T1 (de) Indolizinderivate und deren verwendung als crth2- antagonisten
PE20110588A1 (es) Derivados de benzotiazol como agentes anticancerigenos
DOP2022000282A (es) Compuestos para el tratamiento de enfermedades y trastornos asociados a braf
AR065863A1 (es) Derivados de imidazolidinona
UY28450A1 (es) Compuestos heteroarilo de 6 miembros para el tratamiento de trastornos neurodegenerativos.
PE20060657A1 (es) Derivados de pirimidina como moduladores de ppar-alfa
AR067904A1 (es) Derivados de piperazina-amida
MA38948B1 (fr) Dérivés de 2h-indazole antibactériens
NO20081589L (no) 2-aminoalkoholer for behandling av neurodegenerative sykdommer
RU2010151142A (ru) Замещенные хиназолины
MX25770A (es) Compuestos antidiabeticos y procedimientos para supreparacion.
AR079011A1 (es) Composicion y metodo para controlar plagas de artropodos
AR079009A1 (es) Composicion y metodo para controlar plagas de artropodos
MX2009006246A (es) Derivados de aminoalcohol y su uso terapeutico.
AR047967A1 (es) Derivados de pirimidina utiles para tratar enfermedades de reflujo gastro-esofagico.
AR057300A1 (es) Estirilsulfonamidas, su obtencion y uso como agentes farmaceuticos
AR051849A1 (es) Pirrolo[1,2-a]quinoxalin-5-(4h)-il)sulfonilos y carbonilos y su uso como ligandos de receptores estrogenicos
UY29133A1 (es) Amidas conteniendo (!!2-tert-butil-1-(tetrahidro-2h-piran-4-ilmetil)-1h-bencimidazol-5-!!) (metil)amino!sulfonilo) como sustituyente. procedimiento de preparacion, composiciones que lo contienen y aplicaciones
UY31447A1 (es) Compuestos de bencensulfonanilida apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application